{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:30:31Z","timestamp":1790998231919,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Commission","doi-asserted-by":"publisher","award":["2024KJ180"],"award-info":[{"award-number":["2024KJ180"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.intimp.2026.116577","type":"journal-article","created":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T10:58:52Z","timestamp":1775386732000},"page":"116577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting SERPINE1 enhances PD-1 blockade response by modulating macrophage infiltration and polarization through the STAT3-CCL2 axis in non-small cell lung cancer"],"prefix":"10.1016","volume":"178","author":[{"given":"Youhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaidi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richeng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2026.116577_bb0005","first-page":"229","article-title":"\u201cglobal cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,\u201d (in eng)","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"12","key":"10.1016\/j.intimp.2026.116577_bb0010","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1001\/jamaoncol.2021.4932","article-title":"\u201cupdate of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung Cancer in the US,\u201d (in eng)","volume":"7","author":"Ganti","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.intimp.2026.116577_bb0015","article-title":"\u201crecent developments in PD-1\/PD-L1 blockade research for gastroesophageal malignancies,\u201d (in eng)","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116577_bb0020","first-page":"567","article-title":"\u201cTClC effectively suppresses the growth and metastasis of NSCLC via polypharmacology,\u201d (in eng)","volume":"45","author":"Lu","year":"2025","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12016-025-09105-7","article-title":"\u201cPD-1\/PD-L1 Cancer Immunotherapeutics reshape tumor microenvironment - clinical evidence and molecular mechanisms for AI-based precision medicine,\u201d (in eng)","volume":"68","author":"Lin","year":"2025","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.intimp.2026.116577_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1123244","article-title":"\u201cthe E3 ubiquitin ligases regulate PD-1\/PD-L1 protein levels in tumor microenvironment to improve immunotherapy,\u201d (in eng)","volume":"14","author":"Hou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116577_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.741305","article-title":"\u201ctumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment,\u201d (in eng)","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0040","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","article-title":"Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments, (in eng)","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0045","first-page":"31","article-title":"\u201cPan-cancer analysis reveals tumor-associated macrophage communication in the tumor microenvironment,\u201d (in eng), exp","volume":"10","author":"Wang","year":"2021","journal-title":"Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.intimp.2026.116577_bb0050","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"\u201ctumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer,\u201d (in eng)","volume":"55","author":"Nixon","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.intimp.2026.116577_bb0055","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.omtn.2021.12.036","article-title":"\u201cself-assembled tetrahedral framework nucleic acid mediates tumor-associated macrophage reprogramming and restores antitumor immunity,\u201d (in eng)","volume":"27","author":"Qian","year":"2022","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.intimp.2026.116577_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033967","article-title":"\u201cthe role of angiogenesis and remodeling (AR) associated signature for predicting prognosis and clinical outcome of immunotherapy in pan-cancer,\u201d (in eng)","volume":"13","author":"Sun","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0065","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","article-title":"\u201cdecoding the spatiotemporal heterogeneity of tumor-associated macrophages,\u201d (in eng)","volume":"23","author":"Chu","year":"2024","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12935-024-03518-8","article-title":"\u201cthe axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis,\u201d (in eng)","volume":"24","author":"Yu","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.intimp.2026.116577_bb0075","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1158\/0008-5472.CAN-20-1885","article-title":"\u201ctargeting MARCO and IL37R on immunosuppressive macrophages in lung Cancer blocks regulatory T cells and supports cytotoxic lymphocyte function,\u201d (in eng)","volume":"81","author":"La Fleur","year":"2021","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2022.100028","article-title":"\u201canalysis of immune intratumor heterogeneity highlights immunoregulatory and coinhibitory lymphocytes as hallmarks of recurrence in stage I non-small cell lung Cancer,\u201d (in eng)","volume":"36","author":"Francisco-Cruz","year":"2023","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116577_bb0085","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/cac2.12420","article-title":"\u201chigh baseline tumor burden-associated macrophages promote an immunosuppressive microenvironment and reduce the efficacy of immune checkpoint inhibitors through the IGFBP2-STAT3-PD-L1 pathway,\u201d (in eng)","volume":"43","author":"Wen","year":"2023","journal-title":"Cancer Commun. (Lond.)"},{"issue":"35","key":"10.1016\/j.intimp.2026.116577_bb0090","article-title":"\u201crole of Tunneling nanotubes in arachidonic acid transfer and macrophage function reprogramming in intrahepatic cholangiocarcinoma,\u201d (in eng)","volume":"12","author":"Chen","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.intimp.2026.116577_bb0095","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.178146","article-title":"Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages","volume":"vol. 10","author":"Sato","year":"2025","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13046-025-03490-9","article-title":"\u201ctargeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma,\u201d (in eng)","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2026.116577_bb0105","article-title":"\u201cM2-like TAMs function reversal contributes to breast Cancer eradication by combination dual immune checkpoint blockade and photothermal therapy,\u201d (in eng)","volume":"17","author":"Zhao","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.intimp.2026.116577_bb0110","article-title":"In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy","volume":"vol. 9, no. 389","author":"Arlauckas","year":"2017","journal-title":"(in eng), Sci Transl Med"},{"issue":"18","key":"10.1016\/j.intimp.2026.116577_bb0115","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1158\/0008-5472.CAN-13-3723","article-title":"\u201cCSF1\/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models,\u201d (in eng)","volume":"74","author":"Zhu","year":"2014","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0120","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ki.1997.20","article-title":"\u201cmodulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition,\u201d (in eng)","volume":"51","author":"Oikawa","year":"1997","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.intimp.2026.116577_bb0125","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3892\/ijmm.2013.1234","article-title":"\u201cplasminogen activator inhibitor-1 in kidney pathology (review),\u201d (in eng)","volume":"31","author":"Ma\u0142gorzewicz","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"10","key":"10.1016\/j.intimp.2026.116577_bb0130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1158\/1541-7786.MCR-12-0145","article-title":"\u201crole of plasminogen activator inhibitor-1 in urokinase\u2019s paradoxical in vivo tumor suppressing or promoting effects,\u201d (in eng)","volume":"10","author":"Jing","year":"2012","journal-title":"Mol. Cancer Res."},{"issue":"5","key":"10.1016\/j.intimp.2026.116577_bib271","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.prp.2011.02.008","article-title":"\u201cprognostic importance of PAI-1 in node negative breast cancer patients--results after 10 years of follow up\u201d (in eng)","volume":"207","author":"Eljuga","year":"2011","journal-title":"Pathol. Res. Pract."},{"issue":"19","key":"10.1016\/j.intimp.2026.116577_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202500136","article-title":"\u201cSERPINE1 facilitates metastasis in gastric Cancer through Anoikis resistance and tumor microenvironment Remodeling,\u201d (in eng)","volume":"21","author":"Wang","year":"2025","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12894-023-01217-6","article-title":"\u201cSERPINE1 and its co-expressed genes are associated with the progression of clear cell renal cell carcinoma,\u201d (in eng)","volume":"23","author":"Guo","year":"2023","journal-title":"BMC Urol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13046-024-03269-4","article-title":"\u201cgastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progression,\u201d (in eng)","volume":"44","author":"Ye","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.intimp.2026.116577_bb0155","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jconrel.2020.09.054","article-title":"\u201cCCR2-targeted micelles for anti-cancer peptide delivery and immune stimulation,\u201d (in eng)","volume":"329","author":"Trac","year":"2021","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.intimp.2026.116577_bb0160","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","article-title":"\u201cthe chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis,\u201d (in eng)","volume":"20","author":"Yoshimura","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2026.116577_bb0165","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijrobp.2022.06.054","article-title":"\u201ctumor-derived C-C motif ligand 2 induces the recruitment and polarization of tumor-associated macrophages and increases the metastatic potential of bladder Cancer cells in the Postirradiated microenvironment,\u201d (in eng)","volume":"114","author":"Chiang","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1165\/rcmb.2005-0253OC","article-title":"\u201cthe CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6,\u201d (in eng)","volume":"37","author":"Liu","year":"2007","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2026.116577_bb0175","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/s41419-020-03111-7","article-title":"Targeting tumor cell-derived CCL2 as a strategy to overcome bevacizumab resistance in ETV5(+) colorectal cancer, (in eng)","volume":"11","author":"Feng","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2026.116577_bb0180","article-title":"\u201cSERPINE1 overexpression promotes malignant progression and poor prognosis of gastric Cancer,\u201d (in eng)","volume":"2022","author":"Chen","year":"2022","journal-title":"J. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41392-020-00437-8","article-title":"CREBBP\/EP300 mutations promoted tumor progression in diffuse large B-cell lymphoma through altering tumor-associated macrophage polarization via FBXW7-NOTCH-CCL2\/CSF1 axis, (in eng)","volume":"6","author":"Huang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2026.116577_bb0190","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s004010050647","article-title":"\u201cmonocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas,\u201d (in eng)","volume":"93","author":"Leung","year":"1997","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.intimp.2026.116577_bb0195","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3690561","article-title":"\u201cPIPKI\u03b3 regulates CCL2 expression in colorectal Cancer by activating AKT-STAT3 Signaling,\u201d (in eng)","volume":"2019","author":"Xue","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"10","key":"10.1016\/j.intimp.2026.116577_bb0200","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.jtho.2016.06.021","article-title":"\u201cPleural effusion of patients with malignant mesothelioma induces macrophage-mediated T cell suppression,\u201d (in eng)","volume":"11","author":"Lievense","year":"2016","journal-title":"J. Thorac. Oncol."},{"issue":"4","key":"10.1016\/j.intimp.2026.116577_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019495","article-title":"\"Tumor-associated macrophages recruit CCR6+ regulatory T cells and promote the development of colorectal cancer via enhancing CCL20 production in mice,\" (in eng)","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.intimp.2026.116577_bb0210","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/gutjnl-2015-310016","article-title":"\u201cdual role of tumour-infiltrating T helper 17 cells in human colorectal cancer,\u201d (in eng)","volume":"66","author":"Amicarella","year":"2017","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.intimp.2026.116577_bb0215","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1182\/blood.2020006464","article-title":"\u201cSpatial signatures identify immune escape via PD-1 as a defining feature of T-cell\/histiocyte-rich large B-cell lymphoma,\u201d (in eng)","volume":"137","author":"Griffin","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2026.116577_bb0225","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/jcmm.14027","article-title":"\u201cautocrine VEGF signalling on M2 macrophages regulates PD-L1 expression for immunomodulation of T cells,\u201d (in eng)","volume":"23","author":"Lai","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.intimp.2026.116577_bb0230","doi-asserted-by":"crossref","unstructured":"A. J. Petty et al., \"Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function,\" (in eng), JCI Insight, vol. 6, 6, 12021.","DOI":"10.1172\/jci.insight.146707"},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13058-025-02015-8","article-title":"\u201cAXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization,\u201d (in eng)","volume":"27","author":"Phi","year":"2025","journal-title":"Breast Cancer Res."},{"issue":"13","key":"10.1016\/j.intimp.2026.116577_bb0240","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1002\/cam4.3986","article-title":"\u201ca five-gene signature is a prognostic biomarker in pan-cancer and related with immunologically associated extracellular matrix,\u201d (in eng)","volume":"10","author":"Yu","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2026.116577_bb0245","article-title":"\u201cimmune-related gene SERPINE1 is a novel biomarker for diffuse lower-grade gliomas via large-scale analysis,\u201d (in eng)","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2026.116577_bb0250","article-title":"\u201cOral squamous cell carcinoma contributes to differentiation of monocyte-derived tumor-associated macrophages via PAI-1 and IL-8 production,\u201d (in eng)","volume":"22, no. 17","author":"Kai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2026.116577_bb0255","article-title":"\u201cidentification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis,\u201d (in eng)","volume":"41, no. 4","author":"Ma","year":"2021","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2026.116577_bb0260","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s10565-025-10050-6","article-title":"\u201cNFATC2\/SERPINE1\/JAK3\/STAT3 signaling feedback loop in gastric cancer: immune evasion and anti-PD-1 resistance,\u201d (in eng)","volume":"41","author":"Yang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.intimp.2026.116577_bb0265","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/1742-2094-9-149","article-title":"\u201cplasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity,\u201d (in eng)","volume":"9","author":"Jeon","year":"2012","journal-title":"J. Neuroinflammation"},{"issue":"3","key":"10.1016\/j.intimp.2026.116577_bb0270","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11427-022-2328-x","article-title":"\u201cendothelial extracellular vesicles induce acute lung injury via follistatin-like protein 1,\u201d (in eng)","volume":"67","author":"Yuan","year":"2024","journal-title":"Sci. China Life Sci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926004224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:59:57Z","timestamp":1778619597000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926004224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"alternative-id":["S1567576926004224"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116577","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting SERPINE1 enhances PD-1 blockade response by modulating macrophage infiltration and polarization through the STAT3-CCL2 axis in non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116577"}}